High on Expectations
(Note: related companies are at base of the
story and all the sources listed in the “Balanced” section)
Recently, Canopy Growth Corp (CGC), the Ontario-based cannabis producer, reported a remarkable spike in revenue driven by the company’s first sales of recreational marijuana following recreational legalization in Canada last October. During last quarter, Canopy nearly tripled its quarterly revenue over last year selling 22,271 pounds of weed, 73% of which was recreational. Canopy first made history in 2014 as the first cannabis company to be publicly traded in North America. Since then, Canopy grew to become world’s largest marijuana company by market cap at about $15.2 billion as of market close February 22nd. Canopy, however, is truly only the tip of the iceberg.
The international trend toward legalization combined
with the tremendous amount of investor interest has inspired emerging companies
to bring new products and technologies to market at an exponential rate. The
public small/micro-cap space abounds with unique investment opportunities in
countless emerging cannabis-related markets including pharmaceuticals, cannabidiol
(CBD), hemp, edibles, beverages, vaping equipment, automated joint-rollers, and
everything else you can imagine. Indeed, we stand at the precipice of a
revolution in marijuana consumer and health products.